BIOHAVEN PHARMACTL HLDG CO L (BHVNXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$15
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | $15 | 2,328,602 | 0.00% | 31q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $15 | 2,328,602 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $19.7M | 2,328,602 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $27.0M | 2,387,967 | 1 | 1 | 0 | 0.0% |
| Q3 2025 | 2 | $13.4M | 897,569 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 2 | $12.6M | 897,569 | 0 | 2 | 0 | 0.0% |
| Q1 2025 | 2 | $20.0M | 831,679 | 1 | 1 | 0 | 0.0% |
| Q4 2024 | 2 | $29.0M | 775,152 | 0 | 1 | 0 | 0.0% |
| Q3 2024 | 3 | $36.6M | 731,675 | 1 | 0 | 0 | 0.0% |
| Q2 2024 | 3 | $25.2M | 725,240 | 1 | 1 | 0 | 0.0% |
| Q1 2024 | 2 | $27.6M | 505,152 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 2 | $21.6M | 505,152 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $12.8M | 490,422 | 0 | 1 | 0 | 0.0% |
| Q2 2023 | 1 | $10.8M | 450,422 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 2 | $11.1M | 562,981 | 0 | 0 | 1 | 0.0% |
| Q4 2022 | 2 | $11 | 66 | 1 | 0 | 1 | 0.0% |
| Q3 2022 | 246 | $9.7B | 59,853,651 | 35 | 81 | 91 | 8.9% |
| Q2 2022 | 328 | $9.1B | 61,599,554 | 107 | 98 | 97 | 1.5% |
| Q1 2022 | 307 | $7.8B | 64,145,744 | 53 | 110 | 108 | 2.7% |
| Q4 2021 | 288 | $8.9B | 62,235,444 | 59 | 107 | 82 | 3.6% |
| Q3 2021 | 252 | $8.3B | 58,837,986 | 56 | 75 | 83 | 2.1% |
| Q2 2021 | 226 | $6.0B | 59,745,295 | 40 | 89 | 65 | 2.9% |
| Q1 2021 | 226 | $4.2B | 59,950,417 | 30 | 78 | 89 | 2.8% |
| Q4 2020 | 250 | $5.4B | 56,141,276 | 53 | 79 | 85 | 10.4% |
| Q3 2020 | 215 | $4.0B | 60,096,720 | 20 | 82 | 73 | 3.5% |
| Q2 2020 | 232 | $4.6B | 59,797,179 | 66 | 74 | 64 | 4.3% |
| Q1 2020 | 179 | $2.1B | 57,472,081 | 34 | 68 | 50 | 6.4% |
| Q4 2019 | 191 | $3.0B | 49,572,300 | 29 | 62 | 67 | 8.9% |
| Q3 2019 | 183 | $2.2B | 48,954,816 | 28 | 72 | 58 | 9.2% |
| Q2 2019 | 202 | $2.3B | 45,949,463 | 65 | 81 | 40 | 12.8% |
| Q1 2019 | 174 | $2.1B | 38,441,447 | 51 | 60 | 36 | 4.0% |
| Q4 2018 | 133 | $1.5B | 38,741,613 | 2 | 1 | 2 | 1.5% |